Montefiore - Einstein Heart Center

Daniel J. Goldstein, MD

Montefiore-Einstein Medical Center
3400 Bainbridge Avenue
Bronx, New York 10467
Phone: 718-920-2144
dgoldste@montefiore.org

Positions and Appointments

	2000		Clinical Instructor, Cardiothoracic Surgery Columbia Presbyterian Medical Center, New York, N.Y.

	2000		Assistant Attending, Cardiothoracic Surgery Columbia University, College of Physicians and Surgeons, New York, N.Y.

	2002-2005		Surgical Director of Cardiac Transplantation and Mechanical Assistance Newark Beth Israel Medical Center, Newark, N.J.

	2002-2005		Assistant Director of Cardiothoracic Fellowship Newark Beth Israel Medical Center, Newark, N.J.

	2002-2005		Attending Staff, Department of Cardiothoracic Surgery Newark Beth Israel Medical Center, Newark, N.J.

	2002-2005		Attending Staff, Department of Cardiothoracic Surgery Saint Barnabas Hospital

	2005-present		Associate Professor Albert Einstein College of Medicine, Bronx, N.Y.

	2005-present		Attending Staff, Department of Cardiothoracic Surgery Montefiore Medical Center, Bronx, N.Y.

	2005-present		Surgical Director, Cardiac Transplantation and Mechanical Assistace Programs Montefiore Medical Center, Bronx, N.Y.

	2008 - Present		Co-Director, Center for Advanced Cardiac Therapy Montefiore Medical Center, Bronx, N.Y.

	2008 - Present		Vice Chairman, Department of Cardiovascular and Thoracic Surgery Montefiore Medical Center, Bronx, N.Y.

Education and Training

	1987			Brandeis University, BA with High Honors Waltham, Mass.

	1991			Medical Degree Mount Sinai School of Medicine, New York, N.Y.

	1991-1997			Intern/ Resident, General Surgery Columbia-Presbyterian Medical Center, New York, N.Y.

	1994-1995			Research Fellow, Division of Cardiothoracic Surgery Columbia University, New York, N.Y.

	July-Dec. 1997			Electrophysiology Fellow, Division of Cardiothoracic Surgery Columbia University, New York, N.Y. Supported by a grant from Intermedics Inc., Texas ($23,000)

	Jan. 1998- Dec. 1999			Cardiothoracic Fellow, Division of Cardiothoracic Surgery, Columbia University, New York, N.Y.

	Oct. 1- Nov. 30, 1998			Cardiothoracic Fellow, Division of Thoracic Surgery, Memorial Sloan Kettering Hospital, New York, N.Y.

Board and Other Certifications

	1991		Diplomate of the National Board of Medical Examiners

	1992		Advanced Trauma Life Support

	1996		New York State Infection Control

	1998		Diplomate of the American Board of Surgery

	2000		United Network for Organ Sharing

	2001		Diplomate of the American Board of Thoracic Surgery

Honors and Awards

	1987		Magna Cum Laude Phi Beta Kappa Dean’s List 1984-87

	1991		Alpha Omega Alpha Dr. Harold Lamport Biomedical Research Award - Best Research by Graduating Medical Student

	1994		General Surgery Research Start-Up Award ($1,000)

	1994		Blakemore Research Award for Outstanding Research

	1995		Blakemore Research Award for Outstanding Research

	1995		Claire Lucille Pace Humanitarian Award – Guatemala Heart Team

	1996		Administrative Chief Resident

	1997		Blakemore Research Prize to Graduating Senior for Outstanding Research

	1997		Arnold P. Gold Teaching Resident Award

	1998		Best Teaching Resident of the Year, presented by the Department of Surgery

	2000		Doody’s Rating Top 250 Best Health Science Book, for Minimally Invasive Cardiac Surgery

	2001		Harvey E. Nussbaum, MD, American Heart Association Award for Distinguished Service

	2002		AHA Council on Vascular and Thoracic Surgery Travel Grant ($1,000)

	2005		Member, International Scientific Committee, World Society of Cardiothoracic Surgeons

	2007		“Surgeon of the Year” Award, awarded by the Critical Care Service, Montefiore Medical Center

	2008		Member, American Association for Thoracic Surgery

	2008		New York Times Magazine "Superdoc"

	2009		New York Times Magazine "Superdoc"

	2009		New York Magazine, Best Doctors

	2009-2010		Woodward/White Inc., Best Doctors in America

	2011-2012		Woodward/White Inc., Best Doctors in America

	2009-2011		Who's Who in America

Hospital Committees

	2002-2005		Graduate Medical Education Committee Newark Beth Israel Medical Center, Newark, N.J.

	2005-Present		Outreach Select Standing Committee Montefiore Medical Center, Bronx, N.Y.

	2005-Present		Quality Assessment and Performance Improvement Montefiore Medical Center, Bronx, N.Y.

Memberships

International Society of Heart and Lung Transplantation
American Medical Association
Healing the Children, New York Chapter
American Heart Association Council Member, Cardiothoracic and Vascular Surgery
Fellow, American College of Cardiology
Fellow, American College of Surgeons
Member, Society of Thoracic Surgeons
Member, New York Society for Thoracic Surgery
Member, American Association for Thoracic Surgery
Member, Mechanical Circulatory Support Council, International Society for Heart and Lung Transplantation

Clinical Research Trials/IRB Trials

Newark Beth Israel Medical Center

	2001-2003		Principal Investigator, Safety and Feasibility Trial of the Micromed (Debakey/NASA) Axial Flow Pump as a Bridge to Transplantation ($5,000/patient) - $150,000. Sponsor: MicroMed

	2002-2004		Co-Principal Investigator, Evaluation of Inhaled Nitric Oxide for the Treatment of Right Heart Failure/Pulmonary Hypertension Following LVAD Placement and Cardiac Transplantation ($5,000/patient) - $5000

	2002-2004		Co-Principal Investigator, Multicenter Evaluation of Safety and Efficacy of ERLO80A Compared to Mycophenolate Mofetil in De Novo Heart Transplant Recipients. ($14,252/patient) - $57,000

	2002-2004		Principal Investigator, Clinical Evaluation of Acorn Cardiac Support Device Therapy in Patients with Dilated Cardiomyopathy ($13,000/patient)- $52,000. Sponsor: ACORN Cardiovascular

	2002-2005		Principal Investigator, Multicenter Evaluation of the MicroMed DeBakey VAD as a Bridge to Transplantation: The Pivotal Trial. ($5,000/patient) - $15,000. Sponsor: MicroMed

	2003-2005		Principal Investigator, Randomized Evaluation of the MicroMed DeBakey VAD as Permanent Therapy. ($9,000/patient) - $9,000. Sponsor: MicroMed

Montefiore/Albert Einstein Medical Centers (IRB Approved)

	2005-Present		Principal Investigator, Clinical Evaluation of the HeartMate II Axial Flow Device as a Bridge to Transplant. ($5,500/patient). Sponsor: Thoratec Inc.

	2005-Present		Principal Investigator, Randomized Evaluation of the HeartMate II Axial Flow Device versus the HeartMate XVE as Destination Therapy ($7,500/patient). Sponsor: Thoratec Inc.

	2005-Present		Principal Investigator, The Biology of Human Long-Term Mechanical Support. NHLBI SCCOR Grant. RFA HL-03-009. ($1500 – $7150 per patient) Includes 3 Trials: Epidemiology of Bleeding and Clotting in Patients Undergoing Heart Transplantation or Implantation of Left Ventricular Assist Device Epidemiology of Device-Related Infections The Effect of Intramyocardial Injection of Immunoselected Bone Marrow Cells on Myocardial Function in LVAD Bridge to Transplant Patients
	2005-Present		Principal Investigator, AB 5000 Circulatory Support System Data Registry

	2005-Present		Principal Investigator, Interagency Registry of Mechanically Assisted Circulatory Support

	2005-Present		Co-Investigator, Surgical Treatment for Ischemic Heart Failure (STICH) trial

	2007-Present		Co-Principal Investigator, Montefiore HARPS Protocol – Use of Clenbuterol in Recipients of Ventricular Assist Devices as a Bridge to Recovery

	2007-Present		Co-Principal Investigator, Multicenter, double blind, randomized, placebo-controlled parallel group study to assess the efficacy, safety and tolerability of tezosentan in patients with preoperative pulmonary hypertension, due to left heart disease, undergoing cardiac surgery

	2007-Present		Principal Investigator, Evaluation of the Ventracor Ventricular Assist System as Bridge to Transplantation ($5600 per patient)

	2007-Present		Principal Investigator, Evaluation of the Ventracor Ventricular Assist System as Destination Therapy ($8000 per patient)

	2008-Present		Principal Investigator, Randomized Clinical Trial of Intrinsic Pathway Antagonists in Patients Undergoing Implantation of Left Ventricular Assist Devices

	2008-Present		Co-Principal Investigator, Berlin Heart Excor Pediatric Ventricular Assist Device: Pediatric Clinical IDE Study (IDE G050262)

	2009-Present		Principal Investigator; Clinical Evaluation of the Heartware Left Ventricular Assist Device as Bridge to Transplantation

	2010-Present		Principal Investigator; ENDURANCE: Clinical Evaluation of the Heartware Left Ventricular Assist Device as Destiantion Therapy

Other Activities

	2006-Present		Member, Clinical Events Committee. Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS HF) Trial

	2007-2008		Member, Program Committee. New York State Thoracic Society

	2007-2008		Member, Region 9 Thoracic Review Board

	2007-2008		Member, Steering Committee, Ventrassist Left Ventricular Assist Device Clinical Trials as Bridge to Transplant And Destination Therapy

	2007-Present		Member, Steering Committee, NIH-SCCOR Trial

	2008-Present		Chair, Clinical Events Committee, Terumo LVAD as Bridge to Transplantation Trial

	2008-Present		Medical Advisory Board, Abiomed Inc.

	2009-Present		Medical Advisory Board, New York Organ Donor Network

	2009-Present		Abstract Reviewer, 2010 International Society for Heart and Lung Transplantation Meeting

	2009-Present		INTERMACS – Member, Adverse Event Committee

	2010-Present		Contributor, theheart.org

	2010-Present		Abstract Reviewer, 2011 International Society for Heart and Lung Transplantation Meeting

	2011-Present		Member, Berlin Heart Medical Advisory Board

	2011-Present		Member, Standard and Guidelines Committee, Mechanical Circulatory Support Council

Media Activities

	October 2006		Busca un corazon - El Diario

	April 2007		Es un milagro - El Diario

	2008		New York Times Magazine: New York SuperDocs

	2008		PBS Documentary: The Mysterious Human Heart

	2008		OR-Live; Heart Transplantation – Recipient of Webby Award for Best Live Broadcast on the Internet

	2009		OR-Live; Left Ventricular Assist Device – Live Broadcast

	2009		New York Times Magazine: New York SuperDocs

	July 2009		New York Magazine Best Doctors Issue – My First Heart Transplant

	May 2010		Heartware device supports people who are in severe heart failure - CBS News

Publications and Presentations

Journals

1. Zaghouani H, Goldstein DJ, Shah H, Anderson S, Lacroix M., Kennedy R, Bona C. Induction of antibodies to the envelope protein of the HIV virus by sensitization of rabbits with monoclonal anti-idiotypes. Proc Nat Acad Sci 1991;88(13):5645-49.

2. Oz MC, Goldstein DJ, Rose EA. Adjustable annuloplasty for tricuspid insufficiency. Ann Thorac Surg 1994;58:594-95.

3. Goldstein DJ, El-Amir N, Ashton RA, Catanese K, Rose EA, Levin HR , Oz MC. Fungal infections in left ventricular assist device recipients: incidence, prophylaxis and treatment. ASAIO 1995;41:873-75.

4. Goldstein DJ, Oz MC, Rose EA, Fisher P, Michler RE. Experience with heart transplantation for cardiac tumors. J Heart Lung Transpl 1995;14:382-86.

5. Goldstein DJ, Seldomridge JA, Addonizio L, Oz MC, Michler RE. Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol 1995;75:968-71.

6. Goldstein DJ, Seldomridge JA, Chen JM, Catanese KA, DeRosa CM, Weinberg AD, Smith CR, Rose EA, Levin HR, Oz MC. Use of aprotinin in LVAD recipients reduces blood loss, blood use and perioperative mortality. Ann Thorac Surg 1995;59:1063-68.

7. Goldstein DJ, Mullis SL, Delphin ES, El-amir N, Ashton RC, Gardocki M, Jordan DA, Catanese KA, Levin HR, Oz MC. Non cardiac surgery in long term implantable LVAD recipients. Ann Surg 1995;222:203-07.

8. Slater JP, Goldstein DJ, Ashton RC, Levin HR, Spotnitz HM, Oz MC. Right-to-left venoarterial shunting for right sided circulatory failure. Ann Thorac Surg 1995;60:978-85.

9. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE. De novo malignancies after orthotopic cardiac transplantation. Ann Thorac Surg 1995;60:1783-89.

10. Goldstein DJ, DeRosa CM, Mongero L, Weinberg AD, Michler RE, Rose EA, Oz MC, Smith CR. Safety and efficacy of aprotinin in profound hypothermia and circulatory arrest. J Thorac Cardiovasc Surg 1995;110:1615-22.

11. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson S, Catanese KA, Vargo RL, McCarthy PM, Rose EA, Levin HR. Screening scale predicts patients succesfully receiving long-term implantable LVAD. Circulation 1995;92[suppl II]:II-169-II-173

12. Slater JP, Yamada A, Yano OJ, Stennet R, Goldstein DJ, Levin HR, Spotnitz HM, Oz MC. Creation of a controlled venoarterial shunt: A surgical intervention for right-sided circulatory failure. Circulation 1995;92[suppl II]:II-467-II-471.

13. Goldstein DJ, Oz MC, Michler RE. Radical excisional therapy and cardiac transplantation for recurrent atrial myxoma. Ann Thorac Surg 1995;60:1105-07.

14. Oz MC, Goldstein DJ, Rose EA. Preperitoneal placement of ventricular assist devices: an illustrated stepwise approach. J Cardiac Surg 1995;10:288-94.

15. Rose EA, Goldstein DJ. Wearable long term mechanical support for patients with end-stage heart disease: a tenable goal. Ann Thorac Surg 1996;61:399-402.

16. Goldstein DJ, Smith CR, Oz MC, Friedlander J, Mongero L, Delphin E. Safety of repeat aprotinin administration for left ventricular assist device recipients undergoing cardiac transplantation. Ann Thorac Surg 1996;61:692-95.

17. Goldstein DJ, Austin JHM, Zuech N, Williams DL, Stoopler MB, Michler RE, Schulman LL. Lung cancer after heart transplantation. Transplantation 1996;62(6):772-75.

18. Catanese KA, Goldstein DJ, Williams DL, Foray AT, Illick CD, Gardocki MT, Weinberg AD, Levin HR, Rose EA, Oz MC. Outpatient left ventricular assist device support: a new destination rather than a bridge. Ann Thorac Surg 1996;62:646-53.

19. Beck J, Mongero L, Goldstein DJ, Oz MC. Perfusion technique for the treatment of right heart failure. Perfusion 1995;10:323-26.

20. Ashton RC, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC. Duration of LVAD support affects transplant survival. J Heart Lung Transpl 1996;15:1151-57.

21. Ashton RC, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC. The development of a transluminal device for the treatment of aortic regurgitation: prototype and testing system. J Thorac Cardiovasc Surg 1996;112:979-83.

22. Oz MC, Argenziano M, Catanese KA, Gardocki M, Goldstein DJ, Ashton RC, Rose EA, Levin HR. Bridge experience with long-term implantable left ventricular assist device: are they an alternative to transplantation ?. Circulation 1997;95:1844-52.

23. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin RE, Cohen D. Cyclosporine induced end stage nephropathy after cardiac transplantation; incidence and progression. Transplantation 1997;63:664-68.

24. Holubarsch C, Ruf T, Goldstein DJ, Ashton RC, Nickl W, Pieske B, Pioch K, Ludmann J, Wiesner S, Hasenfuss G, Posival H, Just H, Burkhoff D. Existence of the Frank-Starling mechanism in the failing human heart. Circulation 1996;94:683-89.

25. Goldstein DJ, Ashton RC, Slater JP, Pearson M, Seldomridge JA, D’Alessandro D, Jordan DA, Oz MC. Venoarterial shunting for the treatment of right sided circulatory failure following left ventricular assist device placement. ASAIO J 1997;43(3):171-76.

26. Goldstein DJ, Moazami N, Seldomridge JA, Liao H, Ashton RC, Naka Y, Pinsky DJ, Oz MC. Circulatory resuscitation with 30 day left ventricular assist device reduces interleukins 6 and 8 levels. Ann Thorac Surg 1997;63:971-74.

27. Goldstein DJ, Dean D, Smerling A, Oz MC, Dickstein M. Inhaled nitric oxide Is not a negative inotrope in a porcine model of pulmonary hypertension. J Thorac Cardiovasc Surg 1997;114:461-66.

28. Argenziano M, Dean DA, Moazami N, Williams M, Goldstein DJ, Rose EA, Spotnitz HM, Burkhoff D, Oz MC, Dickstein ML. Inhaled nitric oxide does not alter systolic or diastolic myocardial function in a porcine model of heart failure. J Thorac Cardiovasc Surg 1998;115:700-08.

29. Goldstein DJ, Garfein E, Zuech N, Michler RE. Mitral valve replacement and tricuspid annuloplasty following cardiac transplantation. Ann Thorac Surg. 1997;63:1463-65.

30. Goldstein DJ, DeRosa C, Seldomridge JA, Weinberg AD, Oz MC, Smith CR. Is aprotinin indicated for reoperative valvular surgery?. J Heart Valve Dis 1997;6:88-92.

31. Goldstein DJ, Argenziano M, Oz MC. Permanent mechanical circulatory support: pitfalls and promises. Contemporary Treatments in Cardiovascular Diseases 1997;2:209-25.

32. Goldstein DJ, Flores R, and Todd G. Rupture of non-aneurysmal atherosclerotic infrarenal aorta. J Vasc Surg 1997;26:700-03.

33. Flores RM, Goldstein DJ, Sung RS, Steinglass K, Weinsten S, Chabot JA. Transthoracic transdiaphragmatic excision of simultaneous lung and adrenal lesions. Ann Thorac Surg 1998;65:833-34.

34. Slater JP, Lipsitz EC, Chen JM, Levin HR, Oz MC, Goldstein DJ, Ashton RC, Burkhoff D. Systolic ventricular interaction in normal and diseased explanted human hearts. J Thorac Cardiovasc Surg 1997;113:1091-99.

35. Goldstein DJ, Choudhri A, Argenziano M, Ulmer B, Oz MC. Repeat administration of aprotinin for staged cardiac transplantation. J Circ Support 1998;1:27-30.

36. Argenziano M, Goldstein DJ, Catanese KA, Flannery M, Gardocki MT, Rose EA, Scully BE, Oz MC. Management of infections involving the left ventricular assist device surface. J Circ Support 1998;1:31-36.

37. Farman J, Goldstein DJ, Sugalski M, Moazami N, Amory S. Bouveret’s syndrome: diagnosis by helical CT scan. Clinical Imaging 1998;22:240-42.

38. Harig B, Goldstein DJ, Rosen Y, Farman J. Colonic obstruction due to sigmoid muscle hyperplasia. Mt Sinai J Med 1999;66:106-8.

39. Argenziano M, Dean D, Moazami N, Williams M,Goldstein DJ, Cabreriza S, Burkhoff D, Smerling A, Rose EA, Oz MC, Dickstein M. Inhaled nitric oxide is not a myocardial depressant in a porcine model of heart failure. J Thorac Cardiovasc Surg 1998;115:700-08.

40. Michler RE, Goldstein DJ. Cardiac transplantation for primary cardiac neoplasms. Seminars in Oncology 1997;24:534-39.

41. Goldstein DJ, Losquadro W, Spotnitz HM. Outpatient pacemaker procedures in orally anticoagulated patients. PACE 1998;21:1730-34.

42. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. New Engl J Med 1998;339(21):1522-33.

43. Hart J, Cabreriza S, Jia CX, Umana J, Goldstein DJ, Hill-Edgar A, Weinberg AD, Galantowicz ME, Dickstein M, Burkhoff D, Rose EA, Spotnitz HM. Left ventricular function in a porcine model of dilated cardiomyopathy during left ventricular reduction surgery. Surg Forum 1998;49:246-8.

44. Rose EA, Moskowitz A, Packer M, Sollano J, Williams D, Tierney A, Heitjan D, Meier P, Ascheim D, Levitan R, Weinberg A, Stevenson L, Watson J, Goldstein D, Gelijns A. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure: rationale, design and endpoints. Ann Thorac Surg 1999; 67:723-30.

45. Goldstein DJ, Rabkin D, Spotnitz HM. Unconventional approaches to cardiac pacing in patients with inaccessible cardiac chambers. Ann Thorac Surg 1999;67:952-8.

46. Rabkin D, Goldstein DJ, Flores R, Benvenisty AI. Spontaneous popliteal artery dissection. J Vasc Surg 1999;29:737-40.

47. Goldstein DJ, Oz MC. Minimally invasive cardiac surgery: present status and future directions. Curr Op in Cardiol. 1999:14:419-25.

48. Morales DLS, Catanese KA, Helman DN, Williams MR, Weinberg A, Goldstein DJ, Rose EA, Oz MC. Six-year experience of caring for 44 LVAD patients at home: safe, economical and necessary. J Thorac Cardiovasc Surg 2000;119:251-9.

49. Rabkin D, Sladen R, Dimango A, Steinglass K, Goldstein DJ.Inhaled nitric oxide for the treatment of postpneumonectomy pulmonary edema. Ann Thorac Surg 2001;72:272-4.

50. Goldstein DJ, Oz MC. Mechanical support for postcardiotomy cardiogenic shock. Sem Thorac Cardiovasc Surg 2000;12:220-8.

51. Youssuf A, Karanam R, Prendergast T, Saunders C, Hertz S, Brener B, Sardari F, Goldstein DJ. Combined off pump and carotid revascularization: early experience. Ann Thorac Surg 2001;72:1542-5.

52. Kukuy E, Goldstein D, Rao V, Edwards N, Naka Y. A simple method of creating LVAD outflow anastomosis. Heart Surgery Forum 2002;6(1).

53. Goldstein DJ. Invited Commentary. In: Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg 2002;74:751-2.

54. Goldstein DJ, Beauford R, Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. Multivessel off pump revascularization in patients with severe left ventricular dysfunction. Eur J Cardiothorac 2003;24:72-80.

55. Beauford R, Goldstein D, Luk B, Prendergast T, Sardari F, Burns P, Karanam R, Saunders C. Multivessel off pump revascularization in octagenarians. Ann Thorac Surg 2003 ;76:12-7.

56. Goldstein DJ. Worldwide experience with the MicroMed DeBakey VAD as a bridge to transplantation. Circulation2003;108:II272-7

57. Goldstein DJ, Beauford R. Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 2003;75:S42-7.

58. Beauford R, Saunders CR, Goldstein DJ. Combined off-pump coronary revascularization and carotid endarterctomy. J Cardiovasc Surg 2003;44:407-15

59. Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and Goldstein D. Is off pump revascularization better for patients with non-dialysis dependent renal insufficiency? Heart Surg Forum 2004 7(2):E141-6.

60. Beauford R, Saunders C, Niemeier L, Lunceford T, Karanam R, Prendergast T, Shah S, Burns P, Sardari F and Goldstein D. Multivessel off pump revascularization for patients with left main disease. J Card Surg 2005:20:112-8.

61. Goldstein DJ, Zucker M, Arroyo L, McCarthy P, Noon G. Safety and efficacy trial of the MicroMed DeBakey VAD as a Bridge to transplantation. J Am Coll Cardiol 2005;45:962-3

62. Zucker MJ, Baran DA, Arroyo LH, Goldstein DJ, Neacy C, Mele L, WeinbergAD, Prendergast TW, Ribner HS: De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients ccompared with cyclosporine and mycophenolate mofetil - a one year follow-up analysis. Transpl Proc 2005;37:2231-9

63. Baran DA, Gass Al, Galin I, Zucker M, Arroyo L, Goldstein DJ, Prendergast T, Lubitz S, Courtney M, Correa R, Chan M, Spielvogel D, Lansman S. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device. J Heart Lung Transpl 2005:24:1886-90.

64. Goldstein DJ. Advances in Hematology: Coagulation and Thrombotic Complications Associated with Ventricular Assist Devices. Clin Adv Hematol Oncol 2005 3;10:766-8.

65. Goldstein DJ, Smego D, Michler RE. Surgical aspects in congestive heart failure. Heart Fail Rev. 2006;11:171-192.

66. Baran D, Zucker M, Arroyo L, Alwarshetty M, Ramirez M, Prendergast T, Goldstein D, Camacho M, Gass A, Carr C, Cohen M. Randomized trial of Tacrolimus monotherapy: Tacrolimus in combination, Tacrolimus alone compared (TIC TAC). J Heart Lung Transpl 2007; 26:992-7.

67. Fisher J, Fox M, Kim S, Goldstein D, Haramati L. Asymptomatic anterior perforation of an ICD lead into subcutaneous tissues. PACE 2008;31:7-9.

68. Sylvin E, Stern D, Goldstein D. Mechanical Support for Postcardiotomy Cardiogenic Shock: Has Progress Been Made? J Card Surg 2010;25:442-4.

69. Stern D, Goldstein D. Incidence of Gastrointestinal Bleeding in Recipients of the HeartMate II Left Ventricular Assist Device. J Card Surg 2010;25:352-6.

70. Formica P, Murthy S, Edwards P, Goldstein D, Maybaum S. A structured 3-step approach to evaluate cardiac recovery with continuous flow circulatory support. J Heart Lung Transpl 2010;29:1440-2.

71. Goldstein D, Neragi SM. Mechanical Bridge to Decision: What are the Options for the Management for Acute Refractory Cardiogenic Shock? Curr Heart fail Rep 2011;8:51-8.

Online Contributions

1. Dewey T, Goldstein DJ, Oz MC. TCI Heartmate insertion. Cardiothoracic Surgery Network: Expert’s Techniques. Online: www.ctsnet.org/section/experts, 1999.

2. Rose EA, Goldstein DJ. Role of Left Ventricular Assist Devices as a Bridge to Transplantation. In: Braunwald E, ed. Harrison’s Online. McGraw-Hill 1999.

Book Contributions

1. Goldstein DJ, Costanzo MR, Rose EA. Novel Cardiac Replacement Therapies: A Vision for the Future. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.255-61. 1998

2. Goldstein DJ, Rose EA. Cardiac Allotransplantation. In: Management of End Stage Heart Disease. E.A.Rose and L.W Stevenson, editors. Lippincott-Raven, New York p.177-84. 1998

3. Goldstein DJ, Oz MC. What is Minimally Invasive ? In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.1-5. Humana Press Inc., Totowa, NJ.

4. Lemole G, Choudhri A, Oz MC, Goldstein DJ, Gianguzzi R, Nguyen H. Economic Impact of Minimally Invasive Approaches. In: Minimally Invasive Cardiac Surgery. Mehmet Oz and Daniel Goldstein, Editors. p.165-72. Humana Press Inc., Totowa, NJ.

7. Goldstein DJ, Beauford R, Saunders CR. Beating Heart Revascularization in High-Risk Scenarios: The Patient with Severe Left Ventricular Dysfunction. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003

8. Sardari F, Beauford R, Goldstein DJ. Beating Heart Revascularization in High-Risk Scenarios: The Octagenarian Patient. In: Minimally Invasive Cardiac Surgery. D Goldstein, M. Oz. Editors. Second Edition. Humana Press Inc., Totowa, NJ. Copyright 2003

9. Goldstein DJ, Zucker MJ, Pagani F, Frazier OH. Rotary Ventricular Assist Devices. In: International Society for Heart & Lung Transplantation Monograph Series. Frazier OH, Kirklin JK, eds. Volume 1. p77-104. Copyright 2006

Books

Editorial Activities

Ad Hoc Reviewer for Annals of Thoracic Surgery
Ad Hoc Reviewer for Journal of Thoracic and Cardiovascular surgery
Ad Hoc Reviewer for New England Journal of Medicine
Ad Hoc Reviewer for Journal of Heart and Lung Transplantation
Ad Hoc Reviewer for Transplantation
Ad Hoc Reviewer for PACE
Expert Review of Medical Devices, Editorial Board Member (2006- present)

Selected Abstracts and Presentations

1. Induction of anti-HIV gp160 Antibodies in Rabbit by Sensitization With Monoclonal Anti-Idiotypes Specific for Anti-Envelope Peptide. Presented at the International Conference in AIDS vaccine development: Third Annual Meeting of the National Cooperative Vaccine Development for AIDS, 1990.

2. Use of Aprotinin in LVAD Recipients Reduces Blood Loss and Associated Right Heart Failure. Presented at the Third Meeting of the Society of Thoracic Surgeons, Circulatory Support. Pittsburgh, PA, 1994.

3. Isolated Direct Bilirubinemia in LVAD Patients: Etiology and Prognosis. Presented at the Third Meeting of the Society of Thoracic Surgeons, Circulatory Support. Pittsburgh, PA. 1994.

4. Controlled Veno-Arterial Shunting Can Treat Right Heart Failure in LVAD and Heart Transplant Recipients. Presented at the 67th Scientific Session of the American Heart Association, Dallas, TX, 1993. Circulation 88;4(2) Abstract.

5. Selection Scale Predicts Successfully Patients Receiving Long Term Implantable LVAD. Presented at the 67th Scientific Session of the American Heart Association, Dallas, TX, 1993. Circulation 88;4(2) Abstract.

6. Abiomed Ventricular Assist Device as a Bridge to Transplantation. Presented at the 44th Annual Scientific Sessions of the American College of Cardiology, New Orleans, LA. JACC 1995; Abstract 916-87, 75A.

7. Ventricular Interdependence in Explanted Human Hearts. Presented at the 44th Annual Scientific Sessions of the American College of Cardiology, New Orleans, LA. JACC 1995; Abstract 932-91, 120A.

8. Duration of LVAD Support Affects Transplant Survival. Presented at the 15th Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation, San Francisco, CA, 1994.

9. Perfusion Technique for Treatment of Right Heart Failure. Presented at the Annual Meeting of the American Association of Clinical Perfusion, Palm Springs, CA, 1994.

10. Inhaled Nitric Oxide is Not a Negative Inotrope in a Porcine Model of Pulmonary Hypertension. Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-182 Abstract

11. Circulatory Resuscitation With 30 day Left Ventricular Device Support Reduces Interleukins 6 and 8 Levels. Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-49

12. Long Term Implantable Left Ventricular Assist Devices for Outpatient Therapy of Patients With End Stage Heart Disease: An Alternative to Transplantation? Presented at the 68th Scientific Sessions of the American Heart Association, Anaheim, CA. Circulation 1995;92(8):I-378.

13. Outpatient LVAD Support: A New Destination Rather Than a Bridge. Presented at the Society of Thoracic Surgeons, Orlando, Florida 1995.

14. Inhaled Nitric Oxide is Not a Myocardial Depressant in a Porcine Model of Heart Failure. Presented at the New York Society of Thoracic Surgery, 1996.

15. Cyclosporine-Induced End Stage Nephropathy After Cardiac Transplantation: Incidence and Progression. Presented at the 16th Annual meeting of the International Society for Heart and Lung Transplantation, New York 1996. J Heart and Lung Transplant 1996;15:S99.

16. Liver Dysfunction and Blood Product Replacement After Circulatory Arrest for Aortic Surgery. Anesthesia and Analgesia 1996;82:S108.

17. Experience with Long Term LVAD Support: Implications for Permanent Use. J Heart Lung Transplant 1998;17 [Abstract]:21. Presented at the 18th Annual Meeting of the International Society for Heart Lung Transplantation, Chicago 1998.

18. Left Ventricular Function in a Porcine Model of Dilated Cardiomyopathy During Left Ventricular Reduction Surgery. American College of Surgeons, 1998.

19. Longevity of Lead Systems in Patients with Implantable Cardioverter-Defibrillators: a 13-year Experience. 20th Annual Scientific Sessions North American Society of Pacing and Electrophysiology, Toronto, Ontario, 1999.

20. Right Ventricular Dysfunction and Organ Failure in LVADs: A Continuing Problem. Presented at the Fifth International Conference on Circulatory Support Devices for Severe Cardiac Failure, New York, 2000.

21. Combined Off-Pump Myocardial Revascularization and Carotid Endarterectomy: Early Experience. American College of Surgeons, Chicago, 2000.

22. Adult Cardiac Assist Devices. Sixth Annual Extracorporeal Membrane Oxygenation Meeting, New Jersey, 2001.

23. Transesophageal Echocardiography Identifies High Embolic Risk of Atherosclerotic Plaque and Provides Guidance in Selecting Optimal Surgical Approach for Prevention of Perioperative Stroke. Scientific Sessions, American Heart Association, Anaheim, 2001.

24. Beating Heart Revascularization in Octagenarians: Early Outcome Analysis. Presented at the 5th Annual Meeting of the International Society for Minimally Invasive Cardiac Surgery, 2002. Heart Surg Forum 2002;5:S157.

25. Off Pump Revascularization in Patients With Severe Left Ventricular Dysfunction: Can and Should it be Done? Presented at the 5th Annual Meeting of the International Society for Minimally Invasive Cardiac Surgery, 2002. Heart Surg Forum 2002;5:S158

26. Worldwide Experience with the MicroMed-DeBakey Ventricular Assist Device. Presented at the Scientific Sessions of the American Heart Association, Chicago, 2002.

27. American Experience with the MicroMed DeBakey VAD as a Bridge to Transplantation: Initial Safety and Feasibility Trial. International Society of Heart and Lung Transplantation, Vienna, 2003.

28. Sirolimus-tacrolimus based immunosuppression vs. traditional immunosuppression in de novo heart transplant recipients – a single center analysis. American Transplant Congress, 2003

29. Epidemiology of bleeding and clotting in patients undergoing heart transplantation or implantation of ventricular assist devices. Gordon Research Conference, Montana 2007

30. Impact of mechanical support and device type on outcomes following transplantation. American Heart Association, Orlando 2007

31. The Epidemiology of Bleeding and Clotting in Pulsatile and Continuous Flow LVAD Patients. International Society for Heart and Lung Transplantation, Annual Meeting, Boston 2008

32. The Role of Race in Survival after Heart Transplantation. International Society for Heart and Lung Transplantation, Annual Meeting, Boston 2008

33. The Impact of Donor Mechanism of Death on Survival and Rejection after Heart Transplantation. International Society for Heart and Lung Transplantation, Annual Meeting, Boston 2008

34. Similar Transplant Survival for Non-Recoverable Acute and Chronic Heart Failure Patients Bridged with VADS. International Society for Heart and Lung Transplantation, Annual Meeting, Boston 2008

35. Increased Gastrointestinal Bleeding Following Implantation of the HeartMate II LVAD. International Society for Heart and Lung Transplantation, Annual Meeting, Paris 2009

36. Impact of Donor-Recipient Gender Matching on Survival and Rejection after Cardiac Transplantation. International Society for Heart and Lung Transplantation, Annual Meeting, Paris 2009

37. Normalization of Fixed Pulmonary Hypertension in Severe Heart Failure Patients with Placement of Left Ventricular Assist Device. International Society for Heart and Lung Transplantation, Annual Meeting, Paris 2009

38. Combination of Axial Flow Circulatory Support and Aggressive Neurohormonal Blockade for Recovery of Cardiac Function in Advanced Heart Failure. HFSA 2009, Boston 2009

39. Young Patients with Non-Ischemic Cardiomyopathy Have Higher Likelihood of LV Recovery During HeartMate II Support: Data From the Bridge and Destination Therapy Trials. American Heart Association Meeting, Chicago 2010

40. Cardiac Transplantation in the Septuagenarian: Is 70 the new 60? International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

41. Readmissions Following Continuous Flow LVAD Implantation: Are We Keeping Patients Out of the Hospital Long Enough? International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

42. Driveline infections in LVADs: Is it the pump or the patient? International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

43. Combination Therapy with Pulsatile Left Ventricular Assist Device, Heart Failure Medication and Clenbuterol in Chronic Heart Failure: Results from HARPS. International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

44. Risk for Early Bleeding after MCSD Implant: An analysis of 2358 Patients in INTERMACS. International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

45. Cardiac Improvement with Combined Neurohormonal Blockade and Support With a Continuous Flow LVAD. International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

46. Predictors of Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

47. Infections after Surgery for Advanced Heart Failure (HF): Experience of the NIH CT Surgical Trials Network. International Society for Heart and Lung Transplantation. Annual Meeting April 2011. San Diego

Invited Faculty, CME Talks, Panels

	2001		Heart Transplantation and Mechanical Support. Grand Rounds, Monmouth Medical Center, N.J.

	2001		Left Ventricular Assist Devices. Grand Rounds, Saint Barnabas Hospital, Livingston, N.J.

	2001		Options for Mechanical Support in Adults. Sixth Annual ECMO Conference. Livingston, N.J.

	2001		Surgical Management of Heart Failure. Quarterly Medical Staff Meeting, Newark Beth Israel, Newark, N.J.

	2002		Surgical Management of End-Stage Heart Disease. Grand Rounds, Morristown Memorial Hospital, Morristown, N.J.

	2002		REMATCH Trial: A Paradigm Shift ?. Grand Rounds, Strong Memorial Hospital, Rochester, N.Y.

	2002		Mechanical Support for the Management of Advanced Heart Failure. Heart Council of Long Island Heart Failure Meeting, Melville, N.Y.

	2002		The MicroMed-DeBakey Axial Flow Pump. 42th Annual ASAIO meeting, New York, N.Y.

	2002		Overview of Mechanical Pumps. Moderator. Cleveland Clinic Foundation, STS Circulatory Support Meeting, Cleveland, Ohio.

	2002		Bleeding and LVADs: Adding Insult to Injury. Cleveland Clinic Foundation, STS Circulatory Support Meeting, Cleveland, Ohio.

	2003		Mechanical Support and the REMATCH Trial: The Dawn of a New Era?. Grand Rounds, St-Luke’s-Roosevelt Medical Center, N.Y.

	2003		End-Stage Heart Failure – Heart Transplantation and Beyond. Grand Rounds, Newark Beth Israel, N.Y.

	2003		American Experience With the MicroMed VAD as a Bridge to Transplantation. Investigator’s Meeting. Washington, D.C.

	2003		Selection Criteria for MicroMed VAD Support. Investigator’s Meeting. Washington, D.C.

	2003		Surgical Options in Heart Failure Management. Cardiac Nursing Symposium, Newark, N.J.

	2003		End-Stage Heart Failure – Heart Transplantation and Beyond .Cardiology Grand Rounds, New York University, N.Y.

	2003		Annual Cardiac Symposium, Staten Island University, New York

	2004		Surgical Treatment of Heart Failure: State of the Art. 6th Annual New Jersey Perfusion Symposium. Livingston, N.J.

	2004		My Worse Case Scenario. STS Current Strategies for Heart Failure Management Meeting. Louisville, Ky.

	2005		Surgical Considerations in Device Therapy. Moderator. Mechanical and Biological Cardiac Support Meeting: Recovery, Replacement and Repair. Dallas, Texas.

	2005		LVAD 101. Cardiothoracic Surgery Grand Rounds. Montefiore Medical Center, N.Y.

	2006		2006 State of the Art in Mechanical Support. Cardiology Grand Rounds, Einstein Hospital, N.Y.

	2006		2006 Surgical Options for the Patient with Advanced Heart Failure. General Surgery Grand Rounds. Montefiore Medical Center, N.Y.

	2005		2005 The Bumpy Road to Destination Therapy. First Annual Heart Failure Symposium. Montefiore Medical Center, N.Y.

	2006		2006 What Can the Surgeon Do For You?. Cardiothoracic Surgery Grand Rounds, North Shore Hospital, Manhasset, N.Y.

	2006		2006 Surgical Options for the Patient with Advanced Heart Failure. General Surgery Grand Rounds. Our Lady of Mercy Hospital, Bronx, N.Y.

	2006		Surgical Management of End-Stage Heart Disease. Cardiology Grand Rounds. Maimonides Hospital, Brooklyn, N.Y.

	2007		Acute Myocardial Infarction and Cardiogenic Shock: Role of the Surgeon. St Lukes’ Hospital. Cardiology Grand Rounds. New York, NY

	2007		Bumpy Road to Destination Therapy. Second Annual Heart Failure Symposium. Montefiore Medical Center, New York.

	2008		LVADs: What the Critical Care Doc Needs to Know. Greater New York Heart Association. Annual Critical Care Meeting, New York

	2008		Mechanical Support: State of the Heart. Cardiology Grand Rounds, Beth Israel Medical Center, New York

	2008		LVAD 101, Cardiology Fellow Rounds. Montefiore Medical Center

	2008		Mechanical Support: State of the Heart. Cardiology Grand Rounds, Long Island College Hospital, New York

	2008		Montefiore Experience with the Tandem Assist System. Society for Thoracic Surgeons, San Francisco.

	2008		The Bumpy Road to Destination Therapy. Society for Thoracic Surgeons, San Francisco

	2009		Mechanical Assist Device Support for the Critical Care Intensivist. Annual Greater New York Heart Association meeting, New York.

	2009		What Can We Offer the Patient with End-Stage Heart failure? Medicine Grand Rounds. South Nassau Hospital, Long Island

	2009		Cardiac Recovery During LVAD Support. 4th Annual Heart Failure and Pulmonary Hypertension Summit Meeting. Allegheny Hospital, Pittsburgh, PA.

	2009		What are the Surgical Options for the Patient With Advanced Heart Failure. Medicine Grand Rounds. Lawrence Hospital, Westchester, New York.

	2009		Are We Ready for LVAD Support in the NYHA Class III Patient?. 3rd Annual Success With Heart Failure Meeting. Harvard Club, New York

	2009		Destination Therapy for the Community Cardiologist. Cardiology Grand Rounds. White Plains Hospital, New York.

	2009		Moderator/Chair. International Society of Heart and Lung Transplantation, Annual Meeting, Chicago

	2010		Spanish-American Cardiology Society. Therapies for End Stage Heart Failure. Lincoln Hospital, New York

	2011		Moderator/Chair. International Society of Heart and Lung Transplantation, Annual Meeting, San Diego